FindTrial
Sign In

Feasibility of single high-intensity focused ultrasound ablation for placenta Iincreta

Feasibility of single high-intensity focused ultrasound ablation for placenta increta

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050613
Enrollment
Unknown
Registered
2021-09-01
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placenta increta

Interventions

HIFU Group:No
HIFU combined uterine curettage Group:No

Sponsors

Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Women after vaginal delivery with term pregnancy; 2.Placenta accreta was diagnosed.

Exclusion criteria

Exclusion criteria: 1. Placenta accreta; 2. Major bleeding (blood volume >= 500ml); 3. Co-infection, body temperature >= 38.5 degree; 4. Complicated with serious organic diseases of vital organs: malignant hypertension, history of myocardial infarction, heart failure, liver and kidney failure, etc.

Design outcomes

Primary

MeasureTime frame
chorionic gonadotropin;Adverse events;—

Secondary

MeasureTime frame
Non-perfused volume;—

Countries

China

Contacts

Public ContactChen Jinyun

Chongqing Medical University

chenjinyun2006@126.com+86 13668029697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026